Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02650687 · ClinicalTrials.gov registry record

Optimizing Postoperative Cognition the Elderly

A clinical trial of Postoperative Cognitive Dysfunction and POCD, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
178
Enrollment target
1
Study location

NCT02650687 is a study of Postoperative Cognitive Dysfunction and POCD that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 178 participants, above the 147-participant average among 5 other Postoperative Cognitive Dysfunction trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02650687, a study of Postoperative Cognitive Dysfunction and POCD, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
178 participants
Enrollment target
1
Study location

Study Summary

This study will recruit surgical patients more than 65 years old. Patients who participate will wear a sticker on their forehead during surgery which monitors their brain waves (electroencephalogram, EEG) and participate in memory testing before and after surgery. Brain wave patterns will be compared between patients who have problems with memory and thinking after surgery and those who do not. The hypothesis is that there will be characteristic brain wave patients for who will go on to have problems with memory and thinking after surgery.

Interventions

  • PROCEDURE Processed EEG

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2015-10
Est. Completion 2019-11-14

What the Registry Record Tells You About NCT02650687

The ClinicalTrials.gov registry entry for NCT02650687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 147-participant average among 5 other Postoperative Cognitive Dysfunction trials with a reported enrollment target (21% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Postoperative Cognitive Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Processed EEG is the first listed.

NCT02650687 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02650687 about?

NCT02650687 is a clinical study titled "Optimizing Postoperative Cognition the Elderly". This study will recruit surgical patients more than 65 years old. Patients who participate will wear a sticker on their forehead during surgery which monitors their brain waves (electroencephalogram, EEG) and participate in memory testing before and after surgery. Brain wave patterns will be compare...

What is the current status of trial NCT02650687?

This trial is currently completed. The enrollment target is 178 participants. The study started on 2015-10. Estimated completion is 2019-11-14.

What conditions does trial NCT02650687 study?

This clinical trial studies the following conditions: Postoperative Cognitive Dysfunction, POCD.

What interventions are being tested in trial NCT02650687?

The interventions under investigation include: Processed EEG (PROCEDURE).

Who is sponsoring clinical trial NCT02650687?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02650687 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Cognitive Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.